This story originally ran on July 27 and has been updated to include additional comments.

By Tony Fong

Agilent Technologies continued to bet on the life-science sector on Monday, announcing it plans to spend $1.5 billion to purchase instrument and vacuum company Varian.

From a proteomics perspective, the purchase is not expected to have a profound effect on Agilent, even though Varian has a fleet of LC/MS and Fourier transform mass specs that have use in proteomics and protein analysis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.